Close Menu

NEW YORK (GenomeWeb News) – OncoMethylome today reported that its first-half 2009 revenues fell 17 percent due to one-time up-front fees and milestone payments in 2008 that were not repeated in 2009.

The Liege, Belgium-based molecular diagnostics firm reported revenues of €1.3 million ($1.9 million) for the first six months of 2009, compared to revenues of €1.5 million for the first half of 2008.

Its net loss for the period was €6.3 million, or €.48 per share, versus a net loss of €5.7 million, or €.48 per share, for the first half of 2008.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.

Feb
20
Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

Mar
18
Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.